DS
OMIC

David Shaw’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

David Shaw’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,715
Closed -$19.6K – 4698
2023
Q3 		$19.6K Buy
1,715
+357
+26% +$6.63K ﹤0.01% 3992
2023
Q2 		$33.8K Buy
1,358
+222
+20% +$6.5K ﹤0.01% 3918
2023
Q1 		$41.2K Sell
1,136
-398
-26% -$24.4K ﹤0.01% 4061
2022
Q4 		$92.5K Buy
1,534
+202
+15% +$13.5K ﹤0.01% 4378
2022
Q3 		$100K Sell
1,332
-6,002
-82% -$627K ﹤0.01% 4598
2022
Q2 		$840K Sell
7,334
-1,346
-16% -$158K ﹤0.01% 3746
2022
Q1 		$1.64M Buy
8,680
+6,821
+367% +$1.58M ﹤0.01% 3502
2021
Q4 		$645K Buy
1,859
+770
+71% +$298K ﹤0.01% 4250
2021
Q3 		$366K Buy
+1,089
New +$558K ﹤0.01% 4252

Other funds holding OMIC

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $76.6M AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

David Shaw's OMIC Position: Q4 2023 in Review

David Shaw sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2023, closing a stake of 1,715 shares — an estimated $19.6K sold.

David Shaw first reported a position in OMIC in Q3 2021 and held it in 9 quarters. The position peaked at $1.64M in Q1 2022. 47 funds tracked by Wall St. Rank hold OMIC as of Q4 2023.

  • David Shaw reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • David Shaw sold 1,715 Singular Genomics Systems, Inc. Common Stock shares in Q4 2023, an estimated $19.6K.
  • David Shaw first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • David Shaw's Singular Genomics Systems, Inc. Common Stock position peaked at $1.64M in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.